The Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary Disease-Reference-Cited by-同舟云学术

The Role of Bronchodilators in Preventing Exacerbations of Chronic Obstructive Pulmonary Disease

Published:2016 Issue:4 Volume:79 Page:241
ISSN:1738-3536
Container-title:Tuberculosis and Respiratory Diseases
language:en
Short-container-title:Tuberc Respir Dis

Author:

Beeh Kai M.¹

Affiliation:

1. Insaf Respiratory Research Institute, Wiesbaden, Germany.

Publisher

The Korean Academy of Tuberculosis and Respiratory Diseases

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Link

http://synapse.koreamed.org/pdf/10.4046/trd.2016.79.4.241

Reference42 articles.

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2016 update [Internet]. Global Initiative for Chronic Obstructive Lung Disease. 2016. cited 2016 Jul 9. Available from: http://www.goldcopd.org

2. Chronic Obstructive Pulmonary Disease Phenotypes

3. Seasonal Distribution of COPD Exacerbations in the Prevention of Exacerbations With Tiotropium in COPD Trial

4. Temporal Clustering of Exacerbations in Chronic Obstructive Pulmonary Disease

5. Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. National Development in the Use of Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease: Repeated Cross-Sectional Studies from 1998 to 2018;Biomedicines;2024-02-05

2. Drug Permeability: From the Blood–Brain Barrier to the Peripheral Nerve Barriers;Advanced Therapeutics;2023-02-09

3. Rosa damascena Miller essential oil relaxes rat trachea via KV channels, KATP channels, and BKCa channels;PROSTAG OTH LIPID M;2022

4. Rosa damascena Miller essential oil relaxes rat trachea via KV channels, KATP channels, and BKCa channels;Prostaglandins & Other Lipid Mediators;2022-12

5. Effects of tiotropium on the risk of coronary heart disease in patients with COPD: a nationwide cohort study;Scientific Reports;2022-10-05